836P Safety and efficacy of XMT-1536 in ovarian cancer: A subgroup analysis from the phase I expansion study of XMT-1536, a NaPi2b antibody-drug conjugate
| Autor: | Hamilton, E.P., Barve, M.A., Tolcher, A.W., Buscema, J., Papadopoulos, K.P., Zarwan, C., Anderson, C.K., Doroshow, D., Wang, D., Huebner, D., Jansen, V.M., Jarlenski, D., Mosher, R., Kaufman, J., Moore, K.N., Richardson, D.L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S627-S628 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|